Israa’iil: Shirkadda Galmed oo doonaysa inay $6 bilyan ku dhisto Madal Caafimaad oo ku saabsan Xubinta Dheefshiidka Kadib Markii ay siisatay Colospan
Shirkadda Galmed Pharmaceuticals ee Israa'iil ayaa la wareegaysa Colospan Ltd. si ay u dhisto madal tignoolajiyada caafimaadka ee caloosha iyo mindhicirrada oo qiimihiisu yahay $6 bilyan, iyadoo ka faa'iidaysanaysa aaladda Colospan ee lagu calaamadeeyay CE.
Yeruusaalem, 9 Juun, 2026 (TPS-IL) — Shirkadda dawooyinka ee Galmed Pharmaceuticals oo fadhigeedu yahay Ramat Gan, ayaa saxiixday heshiis kama dambeys ah oo ay kula wareegayso shirkadda Israa’iili ee qalabka caafimaadka ee Colospan Ltd., iyadoo ujeedadu tahay in la dhiso madal tignoolajiyada caafimaadka iyo dawooyinka oo diiradda saarta caloosha iyo mindhicirada, taasoo bartilmaameed u ah suuq dhan $6 bilyan.
Qalabka ugu muhiimsan ee Colospan, CG-100 oo ah qalabka gudaha u gala ee la isku xidho, kaasoo haysta calaamadda CE ee Yurub iyo magacaabista Qalabka Caawinta ee FDA ee Maraykanka, ayaa loogu talagalay in lagu yareeyo dillaaca xubnaha la isku xidhay iyo baahida loo qabo in la isticmaalo tuubooyinka la maroojiyo ka dib qalliinka mindhicirka. Ka dib marka la dhammeeyo, oo la filayo rubucii labaad ee 2026, Colospan waxay noqon doontaa shirkad hoos timaada Galmed. Shirkaduhu waxay sheegeen in heshiisku uu ka faa’iidaysanayo nidaamka hal-abuurka caafimaad ee Israa’iil iyo kaabayaasha shirkadda dadweynaha ee Galmed si loo dardargeliyo ganacsiga caalamiga ah, ugu horrayn Yurub iyo imtixaanada socda ee Maraykanka.
